Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
Eli Lilly jumps deeper into AI with $409M Genetic Leap deal
Genetic Leap use its RNA-targeted AI platform to generate genetic drug candidates against targets selected by Lilly.
Nick Paul Taylor
Sep 5, 2024 9:16am
Lilly posts more positive data on its weekly insulin prospect
Sep 5, 2024 6:45am
UPDATE: Lilly-backed metabolic disease biotech files IPO
Sep 4, 2024 10:23am
Lilly, Haya ink $1B biobuck obesity pact to search dark genome
Sep 4, 2024 8:00am
Lilly taps Oblique for new angle on high-value antibody target
Aug 22, 2024 9:13am
Catalyze360 aims to expand beyond Lilly's core drug ethos
Aug 19, 2024 9:43am